NCT02822092View on ClinicalTrials.gov

Striatal Connectivity and Clinical Outcome in Psychosis

CompletedOBSERVATIONAL

Enrollment

196

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

Psychotic Disorders

Interventions

DRUG

Risperidone or Aripiprazole (patients only)

Inpatients deemed eligible for the study, we be put on open-label risperidone

Trial Locations (1)

11004

Zucker Hillside Hospital, Glen Oaks

Sponsors

Lead Sponsor

Northwell Health

All Listed Sponsors

collaborator

National Institutes of Health (NIH)

NIH

lead

Northwell Health

OTHER